Finance

Lists
524804:BOM
Aurobindo Pharma Ltd
၁,၆၅၈.၆၅ ₹
-၀.၉၈%
(-၁၆.၃၅) 1D
အောက် ၁၆, GMT+၅:၃၀ ၁၅:၃၀:၀၀  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524804...
Open
၁,၆၈၃.၅၅ ₹
High
၁,၆၈၃.၅၅ ₹
Low
၁,၆၅၄.၇၅ ₹
Mkt. cap
ဋေ ၉.၅၉ သ
Avg. vol.
၂.၉၇ သောင်း
Volume
၁.၁၂ သောင်း
P/E ratio
၂၅.၉၂
52-wk high
၁,၇၃၉.၉၅ ₹
52-wk low
၁,၀၈၀.၁၀ ₹
EPS
၆၄.၀၀ ₹
Shares outstanding
၅၈.၅၉ ကုဋေ
No. of employees
၃ သောင်း
Open
၁,၆၈၃.၅၅ ₹
High
၁,၆၈၃.၅၅ ₹
Low
၁,၆၅၄.၇၅ ₹
Mkt. cap
ဋေ ၉.၅၉ သ
Avg. vol.
၂.၉၇ သောင်း
Volume
၁.၁၂ သောင်း
P/E ratio
၂၅.၉၂
52-wk high
၁,၇၃၉.၉၅ ₹
52-wk low
၁,၀၈၀.၁၀ ₹
EPS
၆၄.၀၀ ₹
Shares outstanding
၅၈.၅၉ ကုဋေ
No. of employees
၃ သောင်း
News stories
From web sources and news partners
Profile
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca. Wikipedia
About Aurobindo Pharma Ltd
CEO-
Employees၂.၉၂ သောင်း
Founded၁၉၈၆
HeadquartersHyderabad, အန်ဒရာပရာဒစ် ပြည်နယ်, အိန္ဒိယ
Sector-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
ဋေ ၈.၂၉ ထ
ဋေ ၈.၆၅ ထ
ဋေ ၈.၈၅ ထ
ဋေ ၉.၁၅ ထ
Cost of goods sold
ဋေ ၃.၃၄ ထ
ဋေ ၃.၄၈ ထ
ဋေ ၃.၉၃ ထ
ဋေ ၃.၆၃ ထ
Cost of revenue
ဋေ ၃.၃၄ ထ
ဋေ ၃.၄၈ ထ
ဋေ ၃.၉၃ ထ
ဋေ ၃.၆၃ ထ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
ဋေ ၁.၂၈ ထ
ဋေ ၁.၃၁ ထ
ဋေ ၁.၄၃ ထ
ဋေ ၁.၄၈ ထ
Operating expense
ဋေ ၃.၇၀ ထ
ဋေ ၃.၈၆ ထ
ဋေ ၃.၅၃ ထ
ဋေ ၄.၁၃ ထ
Total operating expenses
ဋေ ၇.၀၄ ထ
ဋေ ၇.၃၄ ထ
ဋေ ၇.၄၆ ထ
ဋေ ၇.၇၆ ထ
Operating income
ဋေ ၁.၂၅ ထ
ဋေ ၁.၃၁ ထ
ဋေ ၁.၄၀ ထ
ဋေ ၁.၃၉ ထ
Other non operating income
၁၁၅.၆၁ ဋေ
၁၅၄.၁၄ ဋေ
-၂၅၁.၄၃ ဋေ
၂၁၁.၆၁ ဋေ
EBT including unusual items
ဋေ ၁.၂၈ ထ
ဋေ ၁.၃၄ ထ
ဋေ ၁.၂၉ ထ
ဋေ ၁.၅၂ ထ
EBT excluding unusual items
ဋေ ၁.၂၈ ထ
ဋေ ၁.၄၀ ထ
ဋေ ၁.၃၆ ထ
ဋေ ၁.၅၆ ထ
Income tax expense
၄၂၇.၇၉ ဋေ
၄၂၈.၇၂ ဋေ
၃၆၉.၇၇ ဋေ
၄၈၃.၀၆ ဋေ
Effective tax rate
၃၃.၅၃%
၃၂.၀၃%
၂၈.၆၅%
၃၁.၈၈%
Other operating expenses
ဋေ ၁.၉၉ ထ
ဋေ ၂.၀၈ ထ
ဋေ ၁.၆၄ ထ
ဋေ ၂.၁၆ ထ
Net income
၈၄၈.၄၅ ဋေ
၉၁၀.၂၉ ဋေ
၉၂၁.၂၆ ဋေ
ဋေ ၁.၀၃ ထ
Net profit margin
၁၀.၂၄%
၁၀.၅၃%
၁၀.၄၁%
၁၁.၂၈%
Earnings per share
၁၄.၆၁
၁၆.၄၃
၁၅.၈၆
၁၇.၄၆
Interest and investment income
-
-
၃၃၁.၃၅ ဋေ
-
Interest expense
-၉၅.၂၄ ကုဋေ
-၉၂.၇၇ ကုဋေ
-၆၆.၅၅ ကုဋေ
-၁၀၁.၆၆ ဋေ
Net interest expenses
-၉၅.၂၄ ကုဋေ
-၉၂.၇၇ ကုဋေ
၂၆၄.၈၀ ဋေ
-၁၀၁.၆၆ ဋေ
Depreciation and amortization charges
၄၂၉.၁၉ ဋေ
၄၆၄.၇၃ ဋေ
၄၆၁.၀၃ ဋေ
၄၈၆.၈၂ ဋေ
EBITDA
ဋေ ၁.၆၇ ထ
ဋေ ၁.၆၇ ထ
ဋေ ၁.၈၀ ထ
ဋေ ၁.၈၀ ထ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ